Tribeca Film Festival pulls Wakefield vaccine film from schedule

tribecaThis isn’t a scientific paper being retracted, but given the subject, and that we led Weekend Reads with it this morning, we think it merits a post: A film by Andrew Wakefield, infamous for the now-retracted paper he co-authored in The Lancet linking autism and vaccines, has been withdrawn from the prestigious Tribeca Film Festival.

The announcement of the Tribeca lineup, which included the film, “Vaxxed: From Cover-Up to Catastrophe,” earlier this week was met with surprise and objections. As of yesterday, however, festival co-founder Robert De Niro defended the screening, saying he and his wife, who have a child with autism, thought it was “critical that all of the issues surrounding the causes of autism be openly discussed and examined.”

De Niro has apparently changed his mind. As per Jezebel, here is De Niro’s statement from this afternoon (Saturday): Continue reading Tribeca Film Festival pulls Wakefield vaccine film from schedule

Weekend reads: Fraudster rises again as filmmaker; Elsevier, open access publisher?; unethical ethics research

booksThe week at Retraction Watch featured the retraction of a paper on the potential dangers of Wi-Fi, and our 3,000th post. Also, have you taken our survey? Here’s what was happening elsewhere: Continue reading Weekend reads: Fraudster rises again as filmmaker; Elsevier, open access publisher?; unethical ethics research

NFL and NYT collide: Did studies on concussion rates leave out necessary data?

National Football LeagueThe National Football League failed to include data from diagnosed concussions in peer-reviewed studies, making the sport look safer than it is, allege the results of an investigation published yesterday in the New York Times. Now, the paper and the NFL are arguing over whether the studies were supposed to include every instance of head injury.

Early studies on concussion rates published in the journal Neurosurgery left out at least 100 instances of of concussions, the Times reported. The Times and the NFL disagree on the implications of studies based on an incomplete data set: Sources told the Times that it’s bad science, while the NFL explains that the studies were “necessarily preliminary.”

Yesterday afternoon, the sports league published a statement saying that the Times story “is contradicted by clear facts” and “sensationalized.” The statement argued that:  Continue reading NFL and NYT collide: Did studies on concussion rates leave out necessary data?

Family squabble over safety of eye therapy forces journal to pull paper

Screen Shot 2016-03-11 at 5.41.35 PM

A father and son are fighting over whether a laser therapy they describe as co-authors of a 2015 paper could be harmful to patients, prompting the journal to retract the article.

The small study suggested that the therapy could safely treat patients with glaucoma. But Tomislav Ivandic — the father — alleges that errors in how the study was reported could lead to harmful doses of laser light for patients receiving the therapy. His son and co-author, Boris Ivandic, maintains that the article is accurate.

To err on the side of patient safety, Photomedicine and Laser Surgery retracted “Effects of Photobiomodulation Therapy on Patients with Primary Open Angle Glaucoma: A Pilot Study.”

The retraction note explains the dispute:

Continue reading Family squabble over safety of eye therapy forces journal to pull paper

Lawsuit couldn’t stop four retractions for diabetes researcher

Mario Saad
Mario Saad

Four expressions of concern in the journal Diabetes have turned into retractions for Mario Saad, a move which he had tried to stop with a lawsuit.

Last August, a judge dismissed Saad’s suit against the American Diabetes Association, which publishes Diabetes, concluding that the expressions of concerns on the papers were not defamation, but part of an “ongoing scientific discourse.” Now, after an investigation at the University of Campinas in Brazil, where Saad is based, and an assessment from an ADA ethics panel (which overturned some of Unicamp’s recommendations), the journal has added to that discourse by turning the EOCs into retractions — and flagging two more of Saad’s papers with EOCs.

Together, the retracted papers have been cited more than 600 times.

As the retraction notes explain, Continue reading Lawsuit couldn’t stop four retractions for diabetes researcher

Chemist fighting to keep PhD asks University of Texas to pay $95k in legal fees

University of Texas

After the University of Texas postponed a hearing to determine whether it should revoke a chemist’s PhD, her lawyer has filed a motion to stop the proceedings, and requested the school pay her $95,099 in lawyer fees and expenses.

This is the second time UT has threatened to revoke Suvi Orr‘s PhD, following a 2012 retraction for a paper that made up part of her dissertation, which the school alleged contained falsified data. UT revoked her degree in 2014, only to reinstate it after she sued. The school is now trying to revoke it again, but the scheduled hearing on March 4 was postponed. Last week, her lawyer filed a motion for final summary judgment requesting that UT stop the proceedings and repay $95,099 in lawyer fees and expenses. The new motion makes a few requests:

Continue reading Chemist fighting to keep PhD asks University of Texas to pay $95k in legal fees

Retractions rise to nearly 700 in fiscal year 2015 (and psst, this is our 3,000th post)

pubmedThis is our 3,000th post, dear reader, and to celebrate we’re presenting you with a wealth of retraction data from fiscal year 2015, courtesy of the U.S. National Library of Medicine.

The biggest take-home: The number of retracted articles jumped from 500 in Fiscal Year 2014 to 684 in Fiscal Year 2015 — an increase of 37%. But in the same time period, the number of citations indexed for MEDLINE — about 806,000 — has only increased by 5%.

To illustrate, we’ve presented the increase in a handy graphic:

Continue reading Retractions rise to nearly 700 in fiscal year 2015 (and psst, this is our 3,000th post)

Paper calls water “a gift from God”

renewableA paper about using solar energy to make water potable has been flagged for citing God.

The shout-out isn’t subtle; in fact, it’s the first sentence of the Introduction in “Solar still with condenser – A detailed review:”

Water is a gift from God and it plays a key role in the development of an economy and in turn for the welfare of a nation.

The paper itself contains a few similarities to a 2010 paper on the same topic, “Active solar distillation—A detailed review,” which also appeared in Renewable and Sustainable Energy Reviews. But that paper phrases the first sentence of the introduction slightly differently: Continue reading Paper calls water “a gift from God”

Poll: Should there be a way to “self-retract” for honest error?

Daniele Fanelli
Daniele Fanelli

This week in Nature, Daniele Fanelli at Stanford made an interesting proposal: Set up a system of “self-retraction” that makes it crystal clear when a paper is pulled for honest error, rather than misconduct.

Fanelli, a whose work we have frequently covered, rightly notes that honest error represents a minority of retractions — around 20%. To remove any hint that a paper contains misconduct, Fanelli proposes designating self-retractions as those where all authors sign the retraction note:

Continue reading Poll: Should there be a way to “self-retract” for honest error?

Biologist’s research under investigation in Sweden after being questioned on PubPeer

Holgersson
Suchitra Sumitran-Holgersson

The University of Gothenburg in Sweden is investigating several papers co-authored by biologist Suchitra Sumitran-Holgersson after they were challenged on PubPeer.

Sumitran-Holgersson already has one retraction under her belt — of a 2005 Blood paper, after another investigation concluded the results “cannot be considered reliable.” Sumitran-Holgersson and her husband, co-author Jan Holgersson, did not sign the retraction notice. Both were based at the Karolinska Institutet (KI) at the time, but have since moved to the University of Gothenburg.

Now, the University of Gothenburg has launched its own investigation of the papers questioned on PubPeer, according to Continue reading Biologist’s research under investigation in Sweden after being questioned on PubPeer